Loading blog post…
A complete guide to treating jowls — the sagging tissue along the lower jaw — including non-surgical options (filler, Botox, threads, Ultherapy) and when surgery is the more appropriate choice.
· By MedSpot Editorial · 5 min read
Jowls — the downward migration of lower facial tissue creating a sagging appearance along the jawline — are one of the most visible signs of facial aging. They result from a combination of factors, and the appropriate treatment depends on which is dominant in each patient.
Jowls form from several converging aging processes:
Volume loss in the midface: As the fat pads of the cheeks and lateral face deflate, the skin they supported descends. The tissue "falls off" the jawbone, creating the jowl bulge below the mandible.
Bone resorption: The mandible (jawbone) recedes with age, reducing the "shelf" the tissue rests on. This allows tissue to descend past the bone margin.
Skin and ligamentous laxity: The retaining ligaments that hold facial tissue in position loosen. The SMAS (superficial musculoaponeurotic system) — the fibromuscular layer connecting facial muscles to skin — loses tone, allowing tissue descent.
Muscle ptosis: The platysma pulls facial tissue downward as it loses support.
Mild jowling (pre-jowl sulcus): A slight shadow or depression just medial to the jowl where the chin meets the mandible. The tissue is beginning to descend but there's no prominent hanging tissue. Non-surgical treatments can produce meaningful improvement here.
Moderate jowling: Definite tissue descent below the mandible; the jawline has lost its clean definition. Non-surgical treatments help; results may be incomplete.
Significant jowling: Prominent hanging tissue, significant skin excess. Non-surgical treatments provide limited improvement. Surgical consultation is appropriate.
The most effective non-surgical jowl treatment. By adding filler to the depression (pre-jowl sulcus) at the jawline — and sometimes the chin — the visible contrast between the jowl and the mandible is reduced. The jowl doesn't lift; the visual step-off is minimized.
Products: Volux XC or Voluma (Juvéderm), Restylane Lyft — firm, high-G-prime products for the structural jawline area.
Amount: 0.5–2 mL at the pre-jowl sulcus; sometimes combined with chin projection to improve the overall lower face profile.
Realistic result: Improved jawline definition in photographs; reduced "double-jaw" appearance. Does not lift the jowl tissue itself — it softens the visual transition.
Nefertiti lift: Botox injected along the platysmal bands and along the lower jawline margin relaxes the downward-pulling platysma muscle. By reducing the muscle's downward pull, the upward-pulling facial muscles have relative dominance — creating mild tissue lifting.
DAO (depressor anguli oris) relaxation: The muscle that pulls the corners of the mouth downward can contribute to jowl appearance. Relaxing it slightly lifts the oral commissure.
Realistic result: 1–3 mm of lifting effect; more visible in the jawline definition than in the jowl tissue itself. A complement to filler, not a standalone jowl treatment.
PDO barbed threads inserted along jaw vectors can mechanically lift jowl tissue toward the cheek. See our thread lift guide for the full breakdown.
Realistic result for jowls: 2–5 mm of lifting; improvement in early-to-moderate jowling. Not appropriate for significant tissue excess — the gathered skin creates puckering rather than a clean lift.
Best use: Combined with filler and Botox for a comprehensive non-surgical lower-face plan in patients with mild-to-moderate jowling.
HIFU ultrasound stimulates collagen in the dermis and SMAS — the same layer surgeons address in facelifts. For jowls, Ultherapy targets the 4.5 mm depth (SMAS) along the jawline and cheek.
Realistic result: Gradual improvement over 3–6 months; progressive collagen tightening at the SMAS level. Works best as prevention or mild correction in patients under 55 with early jowling.
For established jowls: Ultherapy alone is typically insufficient; combined with filler is more effective.
Subdermal radiofrequency at the jawline treats both skin texture and deep tissue laxity. Multiple sessions (3–4) produce progressive improvement.
Best for: Combined skin laxity and texture concern along the jaw; patients with early jowling who also want skin quality improvement.
For meaningful non-surgical jowl improvement, most effective plans combine:
The sum of these is more effective than any single treatment. A provider who recommends only one treatment for significant jowling is likely oversimplifying.
For patients with moderate-to-significant jowls, non-surgical treatments provide limited and temporary improvement. The surgical threshold:
Lower facelift / SMAS facelift: The definitive jowl treatment. Lifts and repositions the SMAS layer; removes skin excess. Results last 7–10 years.
Mini facelift: For patients with less extensive jowling who want surgical improvement without the full downtime of a standard facelift.
Neck lift + facelift: Often combined when both lower face and neck concerns are present.
The honest conversation: If a patient has significant jowling and pursues non-surgical treatments for 2–3 years with only partial results and increasing investment, a facelift consultation is a reasonable and cost-effective next step. The total non-surgical spend often exceeds facelift cost over 5 years.
| Treatment | Cost | Duration | Jowl efficacy (mild) | Jowl efficacy (significant) |
|---|---|---|---|---|
| Filler (pre-jowl + chin) | $1,200–$3,000 | 12–18 months | Moderate | Low |
| Botox Nefertiti | $300–$600 | 3–4 months | Mild | Minimal |
| Thread lift | $1,500–$4,000 | 12–18 months | Moderate | Low |
| Ultherapy (jaw) | $1,500–$2,500 | 12–18 months | Mild-moderate | Low |
| Combination plan | $3,000–$7,000/year | Annual maintenance | Good | Moderate |
| Lower facelift | $10,000–$20,000 | 7–10 years | Excellent | Excellent |
Looking for a lower face rejuvenation provider? Browse providers on MedSpot →